What are the major opportunities in the Nodular Prurigo market? What are the strategies for the Nodular Prurigo market?

For detailed insights on the major opportunities and strategies in the Nodular Prurigo market, Read More

How does the Nodular Prurigo market relate to the overall economy and other similar markets?

For detailed insights on Nodular Prurigo's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Nodular Prurigo market growth? SWOT analysis of the Nodular Prurigo market.

For detailed insights on the key dynamics influencing the Nodular Prurigo market growth and SWOT analysis of the Nodular Prurigo industry, Read More

Global Nodular Prurigo Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Nodular Prurigo Global Market Report 2025

Name: Nodular Prurigo Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo), By Treatment Type (Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants), By Patient Demographics (Adults, Children, Elderly), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Nodular Prurigo Market?

Nodular prurigo, also known as prurigo nodularis, is a chronic skin condition marked by intensely itchy, firm nodules that commonly appear on the arms, legs, and torso. Nodular prurigo is a chronic skin condition of unclear cause involving immune, nerve, and inflammatory factors where persistent itching leads to excessive scratching, worsening the condition and causing scarring, and typically requires long-term dermatological management.

The main types of nodular prurigo are chronic nodular prurigo, acute nodular prurigo, and subacute nodular prurigo. Chronic nodular prurigo refers to a long-lasting form of prurigo characterized by the development of intensely itchy, firm nodules or bumps on the skin. These are used for various treatment types, including topical treatments, systemic treatments, Phototherapy, and immunosuppressants. The various patient demographics include adults, children, and the elderly and are used by various end users such as hospitals, homecare, specialty clinics, and others.

Nodular Prurigo Market Size and growth rate 2025 to 2029: Graph

What Is The Nodular Prurigo Market Size 2025 And Growth Rate?

The nodular prurigo market size has grown strongly in recent years. It will grow from $1.17 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising dermatology consultations, increased awareness among dermatologists, unmet medical need, academic research focus and improvements in diagnostic techniques.

What Is The Nodular Prurigo Market Growth Forecast?

The nodular prurigo market size is expected to see strong growth in the next few years. It will grow to $1.6 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the approval of targeted therapies, increased r&d funding for rare dermatologic conditions, stronger patient advocacy and awareness campaigns, health insurance and reimbursement expansion and companion diagnostics and biomarker development. Major trends in the forecast period include AI-driven diagnostics, gene editing, nanotechnology in drug delivery, biologics innovation, and wearable monitoring devices.

Book your 30 minutes free consultation with our research experts

How Is The Nodular Prurigo Market Segmented?

The nodular prurigo market covered in this report is segmented –

1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo

2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants

3) By Patient Demographics: Adults, Children, Elderly

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo

2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers

3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants

What Is Driving The Nodular Prurigo Market? Increasing Demand For Targeted Therapies Fueling The Growth Of The Market Due To Their Precision And Improved Patient Outcomes

The increasing demand for targeted therapies is expected to propel the growth of the nodular prurigo market going forward. Targeted therapies refer to the medical treatments that specifically target and interfere with molecular pathways involved in the growth and spread of diseases. The rising demand for targeted therapies can be due to their ability to provide more precise treatments with fewer side effects, improving patient outcomes and offering alternatives to traditional, less specific therapies. Nodular prurigo helps drive the development of targeted therapies by presenting a clear unmet medical need involving specific immune pathways such as IL-4, IL-13, and IL-31, which enables the use of biologics that precisely block these inflammatory signals for more effective treatment. For instance, in October 2023, according to NHS England, a UK-based government agency, in England, 11 million hormone replacement therapy (HRT) items were prescribed, up 47% from 2021–22, with around 2.3 million patients receiving prescriptions, marking a 29% year-on-year increase. Therefore, the increasing demand for targeted therapies is driving growth in the nodular prurigo market.

Who Are The Major Players In The Global Nodular Prurigo Market?

Major companies operating in the nodular prurigo market are Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Galderma S.A., Galderma Laboratories L.P. , Incyte Corporation, Kyowa Kirin Co Ltd., LEO Pharma A/S, Maruho Co Ltd., Kiniksa Pharmaceuticals Ltd., Keymed Biosciences Co Ltd., Trevi Therapeutics Inc., Fierce Pharma, Menlo Therapeutics Inc., VYNE Therapeutics Inc., Celldex Therapeutics Inc.

What Are The Key Trends Of The Global Nodular Prurigo Market? Regulatory Approvals Driving Innovation In The Market

Major companies operating in the nodular prurigo market are focusing on getting regulatory approvals to expand market reach and improve patient outcomes. Regulatory approvals refer to the formal authorization granted by governmental or regulatory bodies for a drug, medical device, or treatment to be marketed and used by the public. For instance, in September 2022, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, received FDA approval for Dupixent (dupilumab), the first and only treatment specifically indicated for prurigo nodularis in adults. This approval was based on data from two pivotal Phase 3 trials (PRIME and PRIME2), which demonstrated that Dupixent significantly reduced itch and skin lesions compared to placebo. Dupixent became the only medicine in the U.S. with an approved indication for treating prurigo nodularis, addressing a substantial unmet medical need for approximately 75,000 adults affected by the condition in the U.S.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Nodular Prurigo Market? Incyte Partnered With China Medical System Holdings To Expand Povorcitinib Development And Commercialization In Asia

In April 2024, Incyte Corporation, a US-based pharmaceutical company, partnered with China Medical System Holdings Limited to advance treatments for various autoimmune and inflammatory dermatologic conditions, including non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis, asthma, and chronic spontaneous urticaria. China Medical System Holdings Limited is a Hong Kong-based pharmaceutical company that is involved in nodular prurigo treatment.

What Is The Regional Outlook For The Global Nodular Prurigo Market?

North America was the largest region in the nodular prurigo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nodular prurigo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nodular prurigo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nodular Prurigo Market?

The nodular prurigo market consists of revenues earned by entities by providing services such as diagnosis and clinical evaluation, prescription of topical treatments, phototherapy, biologic therapies, and supportive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The nodular prurigo market also includes sales of products including oral antidepressants, JAK inhibitors, and topical calcineurin inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nodular Prurigo Industry?

The nodular prurigo market research report is one of a series of new reports from The Business Research Company that provides nodular prurigo market statistics, including nodular prurigo industry global market size, regional shares, competitors with a nodular prurigo market share, nodular prurigo market segments, market trends and opportunities, and any further data you may need to thrive in the nodular prurigo industry. This nodular prurigo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abdul Wasay

Nodular Prurigo Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.25 billion
Revenue Forecast In 2034	$1.6 billion
Growth Rate	CAGR of 6.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The nodular prurigo market covered in this report is segmented – 1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo 2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants 3) By Patient Demographics: Adults, Children, Elderly 4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo 2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers 3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Galderma S.A., Galderma Laboratories L.P. , Incyte Corporation, Kyowa Kirin Co Ltd., LEO Pharma A/S, Maruho Co Ltd., Kiniksa Pharmaceuticals Ltd., Keymed Biosciences Co Ltd., Trevi Therapeutics Inc., Fierce Pharma, Menlo Therapeutics Inc., VYNE Therapeutics Inc., Celldex Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Nodular Prurigo Market Characteristics

3. Nodular Prurigo Market Trends And Strategies

4. Nodular Prurigo Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nodular Prurigo Growth Analysis And Strategic Analysis Framework

5.1. Global Nodular Prurigo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Nodular Prurigo Market Growth Rate Analysis

5.4. Global Nodular Prurigo Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Nodular Prurigo Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Nodular Prurigo Total Addressable Market (TAM)

6. Nodular Prurigo Market Segmentation

6.1. Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Nodular Prurigo

Acute Nodular Prurigo

Subacute Nodular Prurigo

6.2. Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topical Treatments

Systemic Treatments

Phototherapy

Immunosuppressants

6.3. Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adults

Children

Elderly

6.4. Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

6.5. Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Idiopathic Chronic Nodular Prurigo

Secondary To Dermatologic Conditions

Neuropathic Causes

Systemic Disease-Associated

Psychogenic Prurigo

6.6. Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Insect Bite-Induced

Allergic Reactions

Drug-Induced Prurigo

Infectious Triggers

6.7. Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Healing Phase Of Chronic Prurigo

Post-Inflammatory Prurigo

Transient Dermatoses

Reaction To Environmental Irritants

7. Nodular Prurigo Market Regional And Country Analysis

7.1. Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nodular Prurigo Market

8.1. Asia-Pacific Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nodular Prurigo Market

9.1. China Nodular Prurigo Market Overview

9.2. China Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nodular Prurigo Market

10.1. India Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nodular Prurigo Market

11.1. Japan Nodular Prurigo Market Overview

11.2. Japan Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nodular Prurigo Market

12.1. Australia Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nodular Prurigo Market

13.1. Indonesia Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nodular Prurigo Market

14.1. South Korea Nodular Prurigo Market Overview

14.2. South Korea Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nodular Prurigo Market

15.1. Western Europe Nodular Prurigo Market Overview

15.2. Western Europe Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nodular Prurigo Market

16.1. UK Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nodular Prurigo Market

17.1. Germany Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nodular Prurigo Market

18.1. France Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nodular Prurigo Market

19.1. Italy Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nodular Prurigo Market

20.1. Spain Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nodular Prurigo Market

21.1. Eastern Europe Nodular Prurigo Market Overview

21.2. Eastern Europe Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nodular Prurigo Market

22.1. Russia Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nodular Prurigo Market

23.1. North America Nodular Prurigo Market Overview

23.2. North America Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nodular Prurigo Market

24.1. USA Nodular Prurigo Market Overview

24.2. USA Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nodular Prurigo Market

25.1. Canada Nodular Prurigo Market Overview

25.2. Canada Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nodular Prurigo Market

26.1. South America Nodular Prurigo Market Overview

26.2. South America Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nodular Prurigo Market

27.1. Brazil Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nodular Prurigo Market

28.1. Middle East Nodular Prurigo Market Overview

28.2. Middle East Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nodular Prurigo Market

29.1. Africa Nodular Prurigo Market Overview

29.2. Africa Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nodular Prurigo Market Competitive Landscape And Company Profiles

30.1. Nodular Prurigo Market Competitive Landscape

30.2. Nodular Prurigo Market Company Profiles

30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Nodular Prurigo Market Other Major And Innovative Companies

31.1. Astellas Pharma Inc.

31.2. Sun Pharmaceutical Industries Limited

31.3. Galderma S.A.

31.4. Galderma Laboratories L.P.

31.5. Incyte Corporation

31.6. Kyowa Kirin Co Ltd.

31.7. LEO Pharma A/S

31.8. Maruho Co Ltd.

31.9. Kiniksa Pharmaceuticals Ltd.

31.10. Keymed Biosciences Co Ltd.

31.11. Trevi Therapeutics Inc.

31.12. Fierce Pharma

31.13. Menlo Therapeutics Inc.

31.14. VYNE Therapeutics Inc.

31.15. Celldex Therapeutics Inc.

32. Global Nodular Prurigo Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nodular Prurigo Market

34. Recent Developments In The Nodular Prurigo Market

35. Nodular Prurigo Market High Potential Countries, Segments and Strategies

35.1 Nodular Prurigo Market In 2029 - Countries Offering Most New Opportunities

35.2 Nodular Prurigo Market In 2029 - Segments Offering Most New Opportunities

35.3 Nodular Prurigo Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Merck & Co Inc. Financial Performance

Table 79: Sanofi S.A. Financial Performance

Table 80: GlaxoSmithKline plc Financial Performance

Table 81: Amgen Inc. Financial Performance

Table 82: Regeneron Pharmaceuticals Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Merck & Co Inc. Financial Performance

Figure 79: Sanofi S.A. Financial Performance

Figure 80: GlaxoSmithKline plc Financial Performance

Figure 81: Amgen Inc. Financial Performance

Figure 82: Regeneron Pharmaceuticals Inc. Financial Performance

Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Pruritus Therapeutics Global Market Report 2025 – By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products), By Route of Administration ...

Caprolactam Global Market Report 2025 – By Raw Material (Phenol, Cyclohexane, Hydroxylamine Sulfate, Other Raw Materials), By Application (Nylon 6 Filaments, Textile Yarn, Nylon 6 Fibers, Engineering Plastics, Printer In...

Neem Extract Global Market Report 2025 – By Type (Leaf Extract, Fruit And Seed Extract, Bark Extract), By Formulation (Dry, Liquid), By Application (Food And Beverages, Pharmaceutical, Nutraceutical, Personal Care And Co...

Isotretinoin Drugs Global Market Report 2025 – By Form (Capsules, Injection), By Indication Type (Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplasia Ossific...

Retinol Global Market Report 2025 – By Type (Natural, Synthetic), By Application (Personal Care And Cosmetics, Dietary Supplements, Food And Beverage, Animal Feed, Other Applications), By Distribution Channel (Offline, O...

Angina Pectoris Drugs Global Market Report 2025 – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs), ...

Propanol Global Market Report 2025 – By Type( Iso-Propanol, N-propanol), By Grade( Technical Grade, Pharmaceutical Grade, Cosmetic Grade, Electronic Grade), By End User( Pharmaceuticals, Chemicals, Personal Care, Printin...

Frequently Asked Questions

What is the definition of the Nodular Prurigo market?

How will the Nodular Prurigo market drivers and restraints affect the market dynamics? What forces will shape the Nodular Prurigo industry going forward?

The Nodular Prurigo market major growth driver - Increasing Demand For Targeted Therapies Fueling The Growth Of The Market Due To Their Precision And Improved Patient Outcomes. For further insights on the Nodular Prurigo market, request a sample here

What is the forecast market size or the forecast market value of the Nodular Prurigo market?

The Nodular Prurigo market size has grown strongly in recent years. The nodular prurigo market size has grown strongly in recent years. It will grow from $1.17 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising dermatology consultations, increased awareness among dermatologists, unmet medical need, academic research focus and improvements in diagnostic techniques. The nodular prurigo market size is expected to see strong growth in the next few years. It will grow to $1.6 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the approval of targeted therapies, increased r&d funding for rare dermatologic conditions, stronger patient advocacy and awareness campaigns, health insurance and reimbursement expansion and companion diagnostics and biomarker development. Major trends in the forecast period include AI-driven diagnostics, gene editing, nanotechnology in drug delivery, biologics innovation, and wearable monitoring devices. For further insights on the Nodular Prurigo market, request a sample here

How is the Nodular Prurigo market segmented?

The nodular prurigo market covered in this report is segmented –
1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo
2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants
3) By Patient Demographics: Adults, Children, Elderly
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo
2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers
3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants For further insights on the Nodular Prurigo market, request a sample here

Which region has the largest share of the Nodular Prurigo market? What are the other regions covered in the report?

Who are the major players in the Nodular Prurigo market?

What are the key trends in the Nodular Prurigo market?

Major trends in the Nodular Prurigo market include Regulatory Approvals Driving Innovation In The Market. For further insights on the Nodular Prurigo market, request a sample here.